Navigation Links
Lipitor Provides Unprecedented Cardiovascular Risk Reductions in,Diabetes Patients with Metabolic Syndrome and in Stroke Patients

escribed cholesterol-lowering therapy in the world, with nearly 133 million patient-years of experience. Lipitor is supported by an extensive clinical trial program involving more than 400 ongoing and completed trials with more than 80,000 patients.

Important US Prescribing Information

Lipitor is a prescription medication. It is used in patients with multiple risk factors for heart disease such as family history, high blood pressure, age, low HDL ("good" cholesterol) or smoking to reduce the risk of a heart attack, stroke, certain types of heart surgery and chest pain.

Lipitor is also used in patients with type 2 diabetes and at least one other risk factor for heart disease such as high blood pressure, smoking or complications of diabetes, including eye disease and protein in urine, to reduce the risk of heart attack and stroke.

Lipitor is used in patients with existing coronary heart disease to reduce the risk of heart attack, stroke, certain kinds of heart surgery, hospitalization for heart failure, and chest pain.

When diet and exercise alone are not enough, Lipitor is used along with a low-fat diet and exercise to lower cholesterol.

Lipitor is not for everyone. It is not for those with liver problems. And it is not for women who are nursing, pregnant or may become pregnant.

Patients taking Lipitor should tell their doctors if they feel any new muscle pain or weakness. This could be a sign of rare but serious muscle side effects. Patients should tell their doctors about all medications they take. This may help avoid serious drug interactions. Doctors should do blood tests to check liver function before and during treatment and may adjust the dose. The most common side effects are gas, constipation, stomach pain and heartburn. They tend to be mild and often go away.

For additional product information, visit www.Lipitor.com.

Contact

Pfizer
Vanessa Aristide, 212-733-3784
Rebecca Hamm,
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
2. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
3. Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
4. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
5. XTL Provides Update on Phase I Clinical Trial of XTL-2125
6. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
7. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
8. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
9. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
10. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
11. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
Post Your Comments:
(Date:7/24/2008)...uscle and Blood Vessel Formation in ... 24 /- Results of a,preclin...dified to express,stromal derived factor-1(alpha) ...dium of rats, which suggest improved heart functio...ngs -- the International Society for,Magnetic Reso...
(Date:7/24/2008)...eeds Oncology Patient Accrual, DENVER, July 24 /P...ent,Organization (RMO), has contracted with five l...h and site management services for their,clinical ...ategy. The new,trials include the following diseas...Metastatic Breast Cancer, Metastatic Sarcoma, Chro...
(Date:7/23/2008)...ic Therapy to Treat the Disease -, WAYNE, N.J. an...l/ --,Bayer HealthCare Pharmaceuticals and Onyx Ph... that The New England Journal of Medicine publishe...xavar(R) (sorafenib),tablets decreased the absolut...esectable hepatocellular carcinoma (HCC), or liver...
(Date:7/23/2008)...uoroPharma Inc., a company developing,breakthrough...n Tomography,(PET) market, announced positive Phas...ed tracer for myocardial perfusion imaging. BFPET ... complete Phase I clinical,development., BFPET is... flow in the,heart (myocardial perfusion). Myocard...
Breaking Medicine Technology:Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 2Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 3Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 4Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 5Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 6Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3ThermoGenesis Announces Receipt of CE Mark for MarrowXpress 28TM 29 6108 1ThermoGenesis Announces Receipt of CE Mark for MarrowXpress 28TM 29 6108 2ThermoGenesis Announces Receipt of CE Mark for MarrowXpress 28TM 29 6108 3Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 6105 1Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 6105 2Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 6105 3Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 6105 4Scientists may have solved an ecological riddle 3701 1Scientists may have solved an ecological riddle 3701 2Perspective 3A Policies must keep pace with genetic progress 3698 1Perspective 3A Policies must keep pace with genetic progress 3698 2
(Date:7/25/2008)...ne is supporting the US Department of Defense and ...olden Phoenix. Operation Golden Phoenix is a, fo...designed to assist, federal, state and local agenc...enarios. Dataline is providing a vital, ad-hoc, se...dical use during the exercise., NORFOLK, Va., Jul...
(Date:7/25/2008)...HAUMBURG, Ill., July 25 /PRNewswire/ -- Sagent Pha...rmaceutical company, today announced that it,has l... antiarrhythmic,indicated for the treatment and pr...illation and hemodynamically unstable ventricular,...gular heart beat.,Sagent,s amiodarone HCl injectio...
(Date:7/25/2008)...finds fluid back-up in esophagus can cause immune ...thDay News) -- The first evidence linking gastroes... discovered by Duke University Medical Center rese...tions was first noted in the 1970s, and since then... percent of asthma patients also experience GERD s...
(Date:7/25/2008)... Whether you are an Olympian, P...ior, there are Five Things You Need to Know about ...I.S.C. Spine and Sports Center , ...08 -- America,s premier athletes are heading to Be...oning and sacrifice in the hopes of capturing an O...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...new test may be an important tool in the fight aga...ical Electroencephalography highlights the use of ...lier, which may lead to improved treatment. The te... detects impaired memory, which is known to preced...
...ile health experts tirelessly warn that the long-t...kin cancer, the short-term effects can be blazingl... beach. Characterized by bright, red skin that is ...unburn is a sure, almost immediate sign that you d...
...alian researchers claim eating pizza regularly red...rcent. The risk of developing colon cancer also fe...hey claimed. The researchers polled 3,300 people w...phagus, throat or colon and 5,000 people who had n...
...mmon painkillers may lower the risk of developing ... the greater the benefit, scientists said on Frida...ct of painkillers, known as non-steroidal anti-inf...ke them are less likely to develop the illness, wh...
Other Medicine News:
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: